BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27567548)

  • 1. Elevated IL-1β expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone.
    Jeon M; Han J; Nam SJ; Lee JE; Kim S
    Chem Biol Interact; 2016 Oct; 258():126-33. PubMed ID: 27567548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zerumbone suppresses IL-1β-induced cell migration and invasion by inhibiting IL-8 and MMP-3 expression in human triple-negative breast cancer cells.
    Han J; Bae SY; Oh SJ; Lee J; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Nam SJ; Kim S; Lee JE
    Phytother Res; 2014 Nov; 28(11):1654-60. PubMed ID: 24890258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STC-1 expression is upregulated through an Akt/NF-κB-dependent pathway in triple-negative breast cancer cells.
    Jeon M; Han J; Nam SJ; Lee JE; Kim S
    Oncol Rep; 2016 Sep; 36(3):1717-22. PubMed ID: 27461417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion.
    Takada Y; Murakami A; Aggarwal BB
    Oncogene; 2005 Oct; 24(46):6957-69. PubMed ID: 16007145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
    D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
    Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
    Kim S; Lee J; Jeon M; Nam SJ; Lee JE
    Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
    Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
    Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated STC‑1 augments the invasiveness of triple‑negative breast cancer cells through activation of the JNK/c‑Jun signaling pathway.
    Han J; Jeon M; Shin I; Kim S
    Oncol Rep; 2016 Sep; 36(3):1764-71. PubMed ID: 27459971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells.
    Kim S; You D; Jeong Y; Yu J; Kim SW; Nam SJ; Lee JE
    Phytomedicine; 2018 Nov; 50():43-49. PubMed ID: 30466991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways.
    Xu W; Chen J; Lin J; Liu D; Mo L; Pan W; Feng J; Wu W; Zheng D
    Int J Mol Med; 2015 Jan; 35(1):177-86. PubMed ID: 25412187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells.
    Jiang F; Li Y; Si L; Zhang Z; Li Z
    Cell Biol Toxicol; 2019 Aug; 35(4):361-371. PubMed ID: 30612216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol promotes migration and invasion of triple-negative breast cancer cells through activation of p38 MAPK and JNK.
    Zhao M; Howard EW; Parris AB; Guo Z; Zhao Q; Yang X
    Mol Carcinog; 2017 Mar; 56(3):849-862. PubMed ID: 27533114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
    Yan F; Wu Z; Li Z; Liu L
    Med Sci Monit; 2020 Sep; 26():e922814. PubMed ID: 32920591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.
    Kim S; Han J; Jeon M; You D; Lee J; Kim HJ; Bae S; Nam SJ; Lee JE
    Tumour Biol; 2016 Aug; 37(8):11397-407. PubMed ID: 26984157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.